<SEC-DOCUMENT>0001193125-18-261529.txt : 20180829
<SEC-HEADER>0001193125-18-261529.hdr.sgml : 20180829
<ACCEPTANCE-DATETIME>20180829121309
ACCESSION NUMBER:		0001193125-18-261529
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20180829
FILED AS OF DATE:		20180829
DATE AS OF CHANGE:		20180829

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KONINKLIJKE PHILIPS NV
		CENTRAL INDEX KEY:			0000313216
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTRONIC & OTHER ELECTRICAL EQUIPMENT (NO COMPUTER EQUIP) [3600]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-05146-01
		FILM NUMBER:		181043483

	BUSINESS ADDRESS:	
		STREET 1:		BREITNER CENTER
		STREET 2:		AMSTELPLEIN 2
		CITY:			AMSTERDAM
		STATE:			P7
		ZIP:			1096 BC
		BUSINESS PHONE:		31 20 59 77777

	MAIL ADDRESS:	
		STREET 1:		BREITNER CENTER
		STREET 2:		AMSTELPLEIN 2
		CITY:			AMSTERDAM
		STATE:			P7
		ZIP:			1096 BC

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	KONINKLIJKE PHILIPS ELECTRONICS NV
		DATE OF NAME CHANGE:	19981217

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHILIPS ELECTRONICS N V
		DATE OF NAME CHANGE:	19930727

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHILIPS NV
		DATE OF NAME CHANGE:	19910903
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d616848d6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">6-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF
FOREIGN ISSUER </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to Rule <FONT STYLE="white-space:nowrap">13a-16</FONT> or <FONT STYLE="white-space:nowrap">15d-16</FONT>
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>of the Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>August&nbsp;29, 2018 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>KONINKLIJKE
PHILIPS N.V. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Royal Philips </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Translation of registrant&#146;s name into English) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Netherlands </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Jurisdiction of incorporation or organization) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Breitner Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive offices) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether
the registrant files or will file annual reports under cover Form 20-F or Form 40-F. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form
20-F&nbsp;&nbsp;&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form 40-F&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the
registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(1):&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule101(b)(7): &#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule <FONT STYLE="white-space:nowrap">12g3-2(b)</FONT> under the Securities Exchange Act of 1934. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Yes&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;&#9746; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Name and address of person authorized to receive notices </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">and communications from the Securities and Exchange Commission: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">M.J. van Ginneken </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Koninklijke
Philips N.V. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Amstelplein 2 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1096 BC Amsterdam &#150; The Netherlands </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This report comprises a copy of the following press release: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Philips convenes Extraordinary General Meeting of Shareholders&#148;, dated August&nbsp;29, 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf, by the
undersigned, thereunto duly authorized at Amsterdam, on the 29<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day of August 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">KONINKLIJKE PHILIPS N.V. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/
M.J. van Ginneken </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Chief Legal Officer) </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g616848g0829183628850.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Press Information </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">August&nbsp;29, 2018 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Philips convenes Extraordinary General
Meeting of Shareholders </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amsterdam, the Netherlands &#150;</B> Royal Philips (NYSE: PHG, AEX: PHIA) today convened an Extraordinary General Meeting
of Shareholders and published the agenda with explanatory notes. In connection with the fundamental progress of Philips&#146; transformation into a solutions-driven health technology company, and further expansion of its leadership positions in the
health technology market, the agenda items are: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">A proposal to strengthen the Supervisory Board with the appointment of Dr.&nbsp;A. Marc Harrison as a member per
October&nbsp;19, 2018. Dr.&nbsp;Harrison (American, 1964) is currently President and Chief Executive Officer of Intermountain Healthcare, a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">not-for-profit</FONT></FONT> health system
based in Salt Lake City (Utah, US) and the largest healthcare provider in the region. A specialist in pediatric critical care, Dr.&nbsp;Harrison has held leadership positions at Cleveland Clinic &#150; including as CEO of Cleveland Clinic Abu Dhabi
&#150; prior to joining Intermountain in 2016. He has <FONT STYLE="white-space:nowrap">in-depth</FONT> knowledge of health systems and the overall healthcare industry in North America, as well as globally. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">A proposal to determine the remuneration for members of the Supervisory Board at broadly median market levels
with effect from October&nbsp;1, 2018. The proposal follows discussions held with shareholders in multiple countries and institutional advisory organizations. It is aimed at attracting and retaining international Supervisory Board members of the
highest caliber and with experience and expertise relevant to Philips&#146; health technology businesses. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The EGM will be held at the
Hilton Amsterdam Hotel (Apollolaan 138, Amsterdam) on Friday, October&nbsp;19, 2018, beginning at 9:30 hours CET. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Click <U>here</U> to view the agenda
with explanatory notes, the binding recommendation and other documents relevant for the EGM. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>For further information, please contact: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Steve Klink </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Philips Group Press Office </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tel.: +31 6 1088 8824 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">E-mail:</FONT> <U>steve.klink@philips.com</U> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g616848g0829183629006.jpg" ALT="LOGO">
 </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g616848g0829183629116.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">August, 2018</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Page: 2</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ksenija Gonciarenko </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Philips
Investor Relations </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tel.: +31 20 59 77055 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">E-mail:</FONT> <U>ksenija.gonciarenko@philips.com</U> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Royal Philips </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people&#146;s health and enabling better outcomes across the
health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company
is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2017 sales of EUR 17.8&nbsp;billion and employs approximately 75,000 employees with
sales and services in more than 100 countries. News about Philips can be found at <U>www.philips.com/newscenter</U>. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g616848g0829183628850.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g616848g0829183628850.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  D +P# 2(  A$! Q$!_\0
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MLOT*GBO:_!7BV/Q5I;2.BQ7D!"SQKTYZ,/8X/Y5YC\5K.WM?&"M JJ9[9)9
MH_BRPS^0%7/@](X\2WT8SY;698_4.N/YFN3&TJ6(P?UA1L[7-\-4G1Q'LF[K
M8Y_Q)K>JQ>*=7CCU.\2-+V9559V  #G  S7I?PGO+J]\.7<EU<2SN+LJ&E<L
M0-B\<UY+XH_Y&W6?^OZ?_P!&-7=_#7Q3H^AZ#=6^HW:PRO=%U4@G(VJ,_H:O
M'T>;!I0C=Z;(G"U+8A\STU.K^)ES<6G@Z26VGDAD$\8WQN5.,^HKQ[3==U=]
M4M%;5+TJ9T!!N&P1N'O7H/Q!\7:)K/A5[2PO5EG,R,%"D< \UY?I?_(6LO\
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MDP#AR!QCT%?19A*A&BG75U?\=3R,(JKJ-4G9V/-]8U:\U_5I;ZZ.^>4@!5'
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M'$^E_"__ "*6C?\ 7C!_Z+6OG/5/^0M>_P#7=_\ T(U]&>%_^12T;_KQ@_\
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..)SJ-R=SNHQC&"Y58_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g616848g0829183629006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g616848g0829183629006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  \ # # 2(  A$! Q$!_\0
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M%QG*'MT-3BL9%5/8*7+IK]PZ&'?)[5J_;[S>\.&YM]5U*V30(K*WCD55\IT
M VCL.N>M=%>Z78:E&8[VS@N%(QB6,-6=;Z=9>'86NKG5[PQK]^2]N<@_7IFN
M>OOBIIB7'V?2K&ZU.7/'EC8I^G!/Z5X'LZM>IS45\]?S;/5YX4H6J/\ KY&'
MXQ^&"06\FH: KX0;I+0G=QZH>OX5YOI?_(7L_P#KNG_H0KU]/B+JT?SWO@S4
MH8#_ ,M '.!^* '\Z\]UF?2KWQE;7VD;EAN)D>2%TVM')N^88_7CU->[@:N)
MY73KJ^FCNG\G8\S%0H\RG2^[8U?!<>OQO?KH.IV<5RLQ$EE< !I0/XAD9]1V
MKI+IOB;>/&K:;8Q&-]R3*T?RG!&>7/KZ5BW?AW3(?B3>:9JJR16^H-YUI<1M
MM*.QR .W7(^H%=#+\.=:3]W:>,M02W/_ "S<OP/P?!_(5S5ZM'G4Y<NJ3UBW
M^*_4VI4ZG*XJ^CMH_P#/]#+NO";*RZCX\\2 JO*VZ2$D^P_P4?C2VGBN5V.G
M> O#BA!PUQ)'U]SS^K&MC3_A3ID4_P!HU6]N=2ESDASL4_7DD_G70W&IV?AZ
MW^SVNC7[11CA+*T)7^E<\\33E[L???;X8KY=?F:QHRCJ_=_%_><G;1_$RZ:1
MUU2P7RWV/$RQ_*< XX0^H[USOB@:XVM:.NN:59P7;7 "7-MC,XR.#@GIQZ=:
MZ+P=XU,UUJ<<FEZE+YMT908(#)Y>>,/CH>!3&N!XS^)MH8$?[#I"[W+C'S@Y
MQC_>"C\#6T)3I59<\(I13=TK=/+S,Y*,Z:Y9-MOJ_,ZOQ?X6A\3Z8(PPBO83
MOMYO[I]#[&N<T3QW/H\PT;Q=%):W47RK=%25<=B<?S''TKT6J>I:38:O;^1J
M%I%<1]@Z]/H>H_"O*I8B/)[*LKQZ=UZ?Y'=4HOFYZ;L_P?J26E_:7\0EL[J&
MXC/\43AA^E8^M236FI6=W+K%M9V<9;>LJ =O4MS7.ZG\+] B4W%M)?6YW8"Q
MS# _,$_K2Z7\+_#S(+BX:\N23RLLP /_ 'R ?UKKCA:,(^U4G;T5_P S"5>I
M)\G*K^K_ ,C$&OW5[<ZEHWA&%II;VY:22]4;51" .,].<\G\*[_PIX9M_#&D
MBUC(DN)#OGFQR[?X#M6G8:;9:5;"WL+6*WB'\,:XS]?4_6K5<V(Q:G'DIJT?
1Q?K_ )&U&AROFF[O\%Z'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g616848g0829183629116.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g616848g0829183629116.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  5 '0# 2(  A$! Q$!_\0
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M^;5;;$?5J7*XVT99C\)I'X(/AK[8Q0H4\_R^>7+=,^_K7(_\*9M_^@U+_P"
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3GN2>Y-%%%<4I.3N]SH225D?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
